For the parent reading a shampoo label at 9pm, the question is small and personal: is this stuff safe for my kid? For the cosmetic chemist behind the bottle, the same question is a multi-month project across 80 regulatory regimes, dozens of restricted-substance lists, and a brief from marketing that says "clean." The Good Face Project, a San Diego SaaS company founded in 2018 by Iva Teixeira and Lena Skliarova-Mordvinova, has spent six years trying to collapse that gap into a software call.
The company began as a consumer skincare app, born out of Teixeira's search for products her child could tolerate [SDVoyager]. It has since pivoted into a B2B platform serving brands, contract manufacturers, ingredient suppliers, and the retailers that sit above them all [Global Cosmetic Industry, 2024].
From a parent's worry to a chemist's console
The pivot is the interesting part. Most beauty-tech stories that start with a worried-parent origin end at a direct-to-consumer brand or a rating app. The Good Face Project went the other way, into the formulation stack itself, which is where the regulatory and reformulation work actually happens.
Its current flagship is CARA, marketed as a conversational assistant for cosmetic chemists. The tool answers real-time queries on formulas, flags allergens, and proposes compliant prototypes against a database the company says spans 250,000 products and 200,000 ingredients [Premium Beauty News, 2024].
Why retailers picked up the phone
The most concrete validation in the file is distributional. The company reports API integrations with Ulta, Walmart, and Sephora, and was selected for Target's accelerator program, which produced certified brand relationships including Odele, a Target exclusive [US Chamber of Commerce, 2023]. Mass and prestige retailers have been quietly building clean-beauty standards for half a decade and need an auditable engine to enforce them at SKU scale; The Good Face Project is positioning itself as that engine.
The seed round, closed in August 2022 at $5.65 million, was led by VMG Catalyst with participation from Capsum (a French formulator), REDO Ventures, Spark Growth Ventures, and EvoNexus [Beauty Independent, 2022] [PRNewswire, August 2022].
| Metric | Value |
|---|---|
| Seed (Aug 2022) | $5.65M |
The team and the bet
| Person | Role | Background |
|---|---|---|
| Iva Teixeira | CEO, Co-Founder | Data-driven beauty tech; founding story tied to her child's skincare needs [SDVoyager] |
| Lena Skliarova-Mordvinova | CTO, Co-Founder | 22+ years in AI, San Diego based [LinkedIn, 2026] |
| Lucas Nanini | Head of Europe & Asia | Regional commercial lead [LinkedIn, 2026] |
The shape of the team, a technical co-founder with two decades in AI paired with a domain-driven CEO and a dedicated international lead, fits a company that thinks its next chapter is cross-border regulatory coverage rather than a U.S. consumer push.
What could go sideways
A seed round in August 2022 with no publicly disclosed follow-on is the first thing a careful reader will notice. The risks worth weighing:
- Funding clock. The disclosed capital is roughly three years old [PRNewswire, August 2022].
- Data provenance. A 200,000-ingredient database is only as defensible as its sourcing and update cadence [Premium Beauty News, 2024].
- Buyer fragmentation. Selling into brands, manufacturers, suppliers, and retailers at once is four motions, not one.
- LLM commoditization. "A ChatGPT for beauty" [Global Cosmetic Industry, 2024] is a useful framing for press, and a difficult one for moats.
The patient at the end of the bottle
My beat is health and bio, and the reason I keep an eye on this category is that cosmetic ingredient exposure is a clinical question dressed in marketing language. Retailer-side ingredient screening, if it works as advertised, moves part of that burden upstream of the purchase and out of the patient's hands.